- Initial payment
- $349
- Renewal
- $349 every 11 weeks
- Advertised supply
- 3-month plan
A subscription with an explicit first invoice
Brello Health advertises compounded sermorelin through a three-month subscription plan. Its product page states that $349 is charged at purchase and that the subscription renews for $349 every eleven weeks. We use those transaction terms as the starting point for this provider review, rather than treating the advertised $116 monthly special as a month-to-month payment option.
The public description includes medication if approved, injection supplies, provider review and support features. That gives readers several concrete items to check against the final order. We have not enrolled, tested the medication or measured the responsiveness of Brello's clinicians or customer-service staff.
Payment precedes the clinical decision
The checkout explanation says customers pay first and then complete the intake form through a telehealth account. Prescription approval follows the provider's review. Brello says patients who are not approved receive a full refund. This payment sequence is important for anyone who expects to speak with a clinician before money is collected.
A separate refund explanation applies after the provider has completed the health review and written a prescription: the page says a refund may exclude a $50 professional-services fee and requests must be made within twenty-four hours of the completed review. These are distinct stages, not one unconditional money-back promise.
Services that accompany the prescription
Brello lists syringes, needles, instructions, an app, virtual fitness and nutrition classes, a community and provider health review. Support and classes may be useful features, but their presence does not establish that a particular visit schedule, laboratory test or individualized monitoring plan is included. Obtain those details from the actual care team.
The page discusses shipping after approval and notes that state conditions can affect timing. A delivery estimate concerns fulfillment, not how soon a clinical question will be answered. Confirm current state eligibility, the dispensing pharmacy, any testing charges and how prescription changes are handled while a prepaid supply remains unused.
A source inconsistency worth resolving
Although the page is titled Compounded Sermorelin and the plan description names sermorelin, one answer about included medication refers to semaglutide. We treat that as an unresolved inconsistency in the provider's published copy. We do not infer that a different drug is included or that two medications come with the plan.
Before paying, request written confirmation of the exact product, quantity, concentration and included services. This is a practical reason to read the invoice and prescription details together. A clear explanation from the provider can resolve the purchasing question; our review cannot silently repair the source and call the correction verified.
The comparison we can support
Brello provides unusually explicit initial-payment and renewal wording, which helps a reader understand cash flow. The eleven-week schedule should be checked against the stated three-month supply, especially before projecting a full year. The refund conditions and medication-name inconsistency are equally important to the purchasing decision.
The compounded preparation is not FDA-approved, as Brello itself discloses. Its statements about focus, motivation or sleep do not establish dependable outcomes for every patient. Discuss the proposed indication, evidence and monitoring with a licensed clinician. This review assesses the documented service and terms, rather than ranking its treatment as clinically superior.
Useful distinctions
- Initial $349 charge disclosed
- Renewal interval explicitly stated
- Supplies and declined-prescription refund described
Limitations to weigh
- Eleven-week renewal differs from calendar quarters
- Published FAQ names another medication
- Post-review refund has separate conditions
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.